Two-year visual outcome of ranibizumab in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
Crossref DOI link: https://doi.org/10.1007/s00417-014-2688-1
Published Online: 2014-06-25
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hata, Masayuki
Tsujikawa, Akitaka
Miyake, Masahiro
Yamashiro, Kenji
Ooto, Sotaro
Oishi, Akio
Nakanishi, Hideo
Takahashi, Ayako
Yoshimura, Nagahisa
Text and Data Mining valid from 2014-06-25